PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the researc...

June 19, 2023 | Monday | News
Cholesgen Enters Collaboration and Licensing Agreement with AstraZeneca for Hypercholesterolemia

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 17, 2023 | Saturday | News
Emgality Shows Promising Results in Landmark Migraine Prevention Trial, Says Eli Lilly Study

Emgality demonstrated robust efficacy for patients consistent with previous studies, although it did not achieve statistical superiority versus active comp...

June 17, 2023 | Saturday | News
Promising Results in Early-Stage Study of Hodgkin Lymphoma with Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy

Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...

June 16, 2023 | Friday | News
PHC Holdings Acquires SciMed (Asia), Expanding Support for Researchers in Asia-Pacific

SciMed offers life science products and services, including ultra-low temperature freezers and CO2 incubators, in Southeast Asia, India, and Oceania. Since...

June 15, 2023 | Thursday | News
Danish National Genome Center Chooses QIAGEN for Oncology Genome Sequencing Variant Interpretation

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its variant interpretation and reporting software, QIAGEN Clinical Insight (QCI) In...

June 14, 2023 | Wednesday | News
Increased Demand for ABA Therapy Requires Precision Treatment Planning to Achieve Timely Access to Care

According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum dis...

June 13, 2023 | Tuesday | News
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced an agreement with The University of Texas MD And...

June 13, 2023 | Tuesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News
PathomIQ and Neuberg Diagnostics Collaborate on AI-based Biomarker Tests for Clinical Use

PathomIQ is a leading provider of AI-enabled tools for prostate, breast, lung and other cancers that enable precision medicine by extracting yet untapped i...

June 07, 2023 | Wednesday | News
Jackson Laboratory Engages in Rare Disease Therapy Research

Researchers led by Cathleen Lutz, Ph.D., are using an exciting new method, preclinical genomic editing, to develop safe, effective therapies for rare disea...

June 07, 2023 | Wednesday | News
MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery

“We are very excited that Bristol Myers Squibb selected MEDiC as a collaborator to advance its oncology discovery programs,” said Kyuho Han, Ph...

June 06, 2023 | Tuesday | News
Merck Study Reveals mRNA Technology as a 'Game Changer' for Vaccine Manufacturers in Asia-Pacific

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA manufacturi...

June 02, 2023 | Friday | News
Agilent BioTek Marks 10 Years of Pioneering Cell Imaging and Microscopy Innovation

Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilent Bio...

June 02, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close